Question 3: The following enablers and opportunities for the routine collection/collation and reporting of cancer stage and recurrence data have been reported to BCNA via our pre-roundtable stakeholder engagement. Please rank the top 5 enablers/opportunities in order of significance? (1 = the most significant enabler/opportunity) Enablers/opportunities 1. There is widespread agreement about the need for cancer stage and recurrence data to inform cancer policymaking and planning 2. The new 10 year Australian Cancer Plan highlights the need for a comprehensive cancer data ecosystem in Australia 3. There is increasing demand for staging data by hospitals and the clinical community to enable service planning and delivery. 4. Cancer Australia’s Cancer Stage, Treatment and Recurrence (STaR) project generated significant insights into methodological approaches regarding registry derived data 5. New technology, such as artificial intelligence, has the potential to automate PBCR processes, saving time and resources. 6. A number of research projects and initiatives underway across Australia are aimed at progressing the routine collection/collation and/or reporting of cancer stage and recurrence data. 7. International initiatives provide important insights that may inform Australia’s approach to national cancer stage and recurrence data collection/collation and reporting 8. The Australian Government and state and territory governments are significantly investing in digital health strategies, initiatives and programs (e.g. Australian Digital Health Agency, MADIP) 9. Changing societal attitudes regarding the use of health data to inform decision-making 10. Increasing use of digital technology within Australia’s health-care system (e.g. electronic prescribing, telehealth) Do you have any additional enablers or opportunities to add?
38
National Roundtable Report
Made with FlippingBook - professional solution for displaying marketing and sales documents online